FX.co ★ Solid Biosciences Stock Drops 4% Due To Wider Loss In Q4

Shares of Solid Biosciences Inc. (SLDB) are currently witnessing a downturn of over 4 percent after the company disclosed a surge in its fourth-quarter losses.

The life sciences firm experienced a rise in its quarterly net loss, from $15.2 million to $20.3 million. This was primarily attributed to higher yields on cash equivalents and available-for-sale securities, which neutralized the gains accrued from acquisition and collaboration revenue in 2022.

At present, Solid Biosciences' stock is experiencing a 4.65 percent decrease, trading at $10.87, down from its previous closing price of $11.40 on the Nasdaq.

The company's share price has fluctuated between $1.81 and $12.20 over the past year.